Last reviewed · How we verify
Galatone (glyconiazide)
Galatone (generic name: glyconiazide) is a glyconiazide drug. It is currently in unknown development.
Galatone works by inhibiting the reabsorption of glucose in the kidneys, allowing excess glucose to be excreted in the urine.
Galatone, also known as glyconiazide, is a small molecule drug in the glyconiazide class. Its exact target and mechanism of action are unknown, and it has not been approved by the FDA for any indications. The commercial status of Galatone is unclear, with no information available on its patent status or generic manufacturers. Further research is needed to determine the safety and efficacy of this compound. As a result, Galatone is not currently available for clinical use.
At a glance
| Generic name | glyconiazide |
|---|---|
| Drug class | glyconiazide |
| Therapeutic area | Nephrology |
| Phase | unknown |
Mechanism of action
Think of it like a sponge that soaks up water. In the kidneys, there's a sponge-like mechanism that helps reabsorb glucose from the urine back into the bloodstream. Galatone blocks this sponge, allowing excess glucose to be removed from the body.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Galatone CI brief — competitive landscape report
- Galatone updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Galatone
What is Galatone?
How does Galatone work?
What is the generic name of Galatone?
What drug class is Galatone in?
What development phase is Galatone in?
Related
- Drug class: All glyconiazide drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Nephrology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing